Atlas Trials

Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy

Clinical trial NCT04428554 · RECRUITING

Trial details

NCT number
NCT04428554
Sponsor
Institut Claudius Regaud
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Urothelial Bladder Cancer
Start date
2020-06-30
Primary completion
2031-07-01
Enrollment
130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.